Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 14, 2022 ZNTL S 10b5-1 534 $50.16 $26,785 16,045 Direct -3.22% Disposed -95.0% (price as of 2026-10-02)
Feb. 14, 2022 ZNTL S 10b5-1 67 $50.75 $3,400 15,978 Direct -0.42% Disposed -95.0% (price as of 2026-10-02)
Jan. 20, 2022 ZNTL S 10b5-1 8,343 $60.52 $504,918 7,907 Direct -51.34% Disposed -95.8% (price as of 2026-10-02)
Jan. 20, 2022 ZNTL S 10b5-1 1,657 $61.21 $101,425 6,250 Direct -20.96% Disposed -95.9% (price as of 2026-10-02)
Jan. 19, 2022 ZNTL S 10b5-1 7,889 $60.55 $477,679 8,361 Direct -48.55% Disposed -95.8% (price as of 2026-10-02)
Jan. 19, 2022 ZNTL S 10b5-1 1,556 $61.51 $95,710 6,805 Direct -18.61% Disposed -95.9% (price as of 2026-10-02)
Jan. 19, 2022 ZNTL S 10b5-1 555 $62.24 $34,543 6,250 Direct -8.16% Disposed -96.0% (price as of 2026-10-02)
Jan. 18, 2022 ZNTL S 10b5-1 3,409 $61.70 $210,335 12,841 Direct -20.98% Disposed -95.9% (price as of 2026-10-02)
Jan. 18, 2022 ZNTL S 10b5-1 3,294 $62.34 $205,348 9,547 Direct -25.65% Disposed -96.0% (price as of 2026-10-02)
Jan. 18, 2022 ZNTL S 10b5-1 1,997 $63.48 $126,770 7,550 Direct -20.92% Disposed -96.0% (price as of 2026-10-02)
Jan. 18, 2022 ZNTL S 10b5-1 1,300 $64.66 $84,058 6,250 Direct -17.22% Disposed -96.1% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 10, 2022 ZNTL Stock Option (Right to Buy) Common Stock (24,234) $52.61 Feb. 9, 2032 24,234 Acquired
Jan. 20, 2022 ZNTL Stock Option Common Stock (10,000) $18.00 March 25, 2030 10,000 Disposed
Jan. 19, 2022 ZNTL Stock Option Common Stock (10,000) $18.00 March 25, 2030 10,000 Disposed
Jan. 18, 2022 ZNTL Stock Option Common Stock (10,000) $18.00 March 25, 2030 10,000 Disposed
Feb. 11, 2021 ZNTL Stock Option (Right to Buy) Common Stock (18,750) $38.76 Feb. 10, 2031 18,750 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 6, 2026 RADX Option (right to buy)→ Ordinary Shares (7,657,333) 7,657,333 Direct
May 6, 2026 RADX Option (right to buy)→ Ordinary Shares (7,657,333) 7,657,333 Direct
May 6, 2026 RADX Option (right to buy)→ Ordinary Shares (7,657,334) 7,657,334 Direct
April 3, 2020 ZNTL Stock Option→ Common Stock (154,949) 154,949 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ZNTL

M.D.SVP, Clinical Development
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $472 · $242,250 $477,082 $175,874 · $15,282 $1,382,546

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.